D3- versus D2-Dissektion beim Magenkarzinom Eine Fall-Kontroll-Studie hinsichtlich postoperativer Morbidität, Letalität und onkologischen Frühergebnissen

Bittorf, B.; Günther, Franziska; Merkel, Susanne; Horbach, Thomas; Hohenberger, Werner; Günther, Klaus

doi:10.1007/s00104-002-0457-x

Cited by 6 publications

(4 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lymph nodes of compartment D1, including stage 7 (left gastric artery) in compartment D2, were removed en bloc with the resected gastric specimen. All other lymph nodes were defined by the surgeon and dissected individually during surgery [ 7 , 8 ]. We did not perform any prophylactic pancreatectomy or splenectomy.…”

Section: Resultsmentioning

confidence: 99%

“…Some studies have found advantages in Roux-en-Y reconstruction, but this was not confirmed in other studies. The method learned by the surgeon and the associated operative experience undoubtedly play a major role [ 8 , 10 , 13 , 22 – 30 ].…”

Section: Discussionmentioning

confidence: 99%

“…D3 dissection was introduced in the early 1990s in Japan. In Erlangen, it was adopted and developed until 1995 [ 7 , 8 ]. The benefit of the extended lymph node dissection is still under discussion.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center

et al. 2021

View full text Add to dashboard Cite

IntroductionGastric cancer remains the fourth leading cause of cancer-related death in Europe, while the proportion of the adenocarcinomas of the esophagogastric junction has risen by more than one third over recent years. In 2018, 14,700 new cases of gastric cancer were estimated in Germany, while the 5-year relative survival rate is reported to be 33% for women and 30% for men; in the U.S.A. was reported almost the same rate with 31% 5-year survival.Material and methodsBetween 2001 and 2014, 590 patients with a diagnosis of gastric cancer underwent surgery in our institution, including 120 Siewert type II/III carcinomas of the esophagogastric junction. All patients underwent distal resection of the stomach, gastrectomy or total gastrectomy combined with transhiatal distal esophageal resection. All operations included D2-D3 lymph node dissection. Data was recorded by the cancer registry of the department of surgery and analyzed retrospectively.ResultsThe patients were classified according to the TNM (UICC 2010) and Lauren classification. 29% of the patients underwent primary surgery and 31% received neo-adjuvant therapy. The median number of harvested lymph nodes was 33 for patients diagnosed with gastric cancer, and 29 for esophagogastric adenocarcinomas, respectively. The anastomotic leak rate was 3%. In this study, the 5-year overall survival rate was 51% concerning gastric carcinomas, 44% for Siewert type II and 47% for Siewert III cancers carcinomas of the esophagogastric junction.ConclusionsIncreased survival with low complication rates were achieved after individualized and multimodal treatment concepts combined with consistently applied extended lymphadenectomy.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In Chinese studies mortality and morbidity of D2 dissection was reported to be higher than D1 dissection, Finnish studies showed that D2 -3 dissection had higher complication rates as compared to D1 dissection and in Europe D2 -3 dissection is reported to carry an acceptable rate of mortality (17,18). German series also reported that D3 dissection is not superior to D2 dissection and D3 dissection has disadvantages (19,20). In our study, the greater omentum, D1 lymph node dissection, and 7, 8, 9 lymph nodes were removed as part of total gastrectomy.…”

Section: Discussionmentioning

confidence: 99%

D1 versus D2 dissection in stomach carcinoma: evaluation of postoperative mortality and complications

Vural

Saylam

Çomçalı

et al. 2013

UCD

View full text Add to dashboard Cite

show abstract

Magenkarzinom

Siewert¹,

Sendler²,

Lordick³

Praxis Der Viszeralchirurgie

View full text Add to dashboard Cite

D3- versus D2-Dissektion beim Magenkarzinom Eine Fall-Kontroll-Studie hinsichtlich postoperativer Morbidität, Letalität und onkologischen Frühergebnissen

Abstract: Compared to the D2 method, D3 dissection is feasible without disadvantages in the patients. However, D3 dissection cannot routinely be recommended because--possibly due to the short follow-up period and the small number of patients so far observed--an oncologic benefit could not be shown.

Cited by 6 publications

References 33 publications

Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center

Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center

D1 versus D2 dissection in stomach carcinoma: evaluation of postoperative mortality and complications

Magenkarzinom

Contact Info

Product

Resources

About